click below
click below
Normal Size Small Size show me how
Endocrine Final
| Generic | MOA | Class |
|---|---|---|
| Glimepiride | K+ -ATP channel inhibitor at SUR1 | Sulfonylureas |
| Glipizide | K+ -ATP channel inhibitor at SUR1 | Sulfonylureas |
| Glyburide | K+ -ATP channel inhibitor at SUR1 | Sulfonylureas |
| Dulaglutide | Agonist at pancreatic GLP-1 receptor | GLP-1 Agonist |
| Liraglutide | Agonist at pancreatic GLP-1 receptor | GLP-1 Agonist |
| Semaglutide | Agonist at pancreatic GLP-1 receptor | GLP-1 Agonist |
| Tirzepatide | Agonist at GLP-1 AND GIP receptor | GIP Agonist |
| Cortisol | GR agonist (w/ MR activity) | Natural Glucocorticoids |
| Dexamethasone | GR agonist (GR >>> MR) | Synthetic Glucocorticoids |
| Methylprednisolone | GR agonist ( w/ MR activity) | Synthetic Glucocorticoids |
| Prednisone/ Prednisolone | GR agonist (w/ MR activity) | Synthetic Glucocorticoids |
| Triamcinolone | GR agonist (GR >>> MR) | Synthetic Glucocorticoids |
| Aldosterone | MR agonist, increased Na+/ K+ excretion at DCT and collecting duct | Natural Mineralocorticoids |
| Fludrocortisone | MR agonist, increased Na+/ K+ excretion at DCT and collecting duct | Synthetic Mineralocorticoids |